Hikma Pharmaceuticals (LON:HIK) Stock Price Crosses Above 200 Day Moving Average – Time to Sell?
Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1,922.34 ($24.05) ...
Hikma Pharmaceuticals rises Tuesday, still underperforms market
Hikma Pharmaceuticals PLC HIK shares inched up 0.45% to £19.93 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.64% to 8 ...
Hosted on MSN2d
FDA Approves First Generic Liraglutide Injection, Ushering in a New Era for Type 2 Diabetes Treatment
The fight against type 2 diabetes just reached a groundbreaking milestone. Last week, the U.S. Food and Drug Administration ...
Becker's Hospital Review2d
5 Ozempic updates
Stay updated on the latest developments in the GLP-1 drug class, including a new generic entering the market, weight loss results, FDA decisions & cost issues.
Insider Monkey4d
Is Hikma Pharmaceuticals PLC (HIK.L) Among the U.K. Dividend Aristocrats for 2024?
In this article, we are going to take a look at where Hikma Pharmaceuticals PLC (LON:HIK.L) stands against the other U.K.
Hikma Pharmaceuticals falls Friday, underperforms market
Shares of Hikma Pharmaceuticals PLC HIK inched down 0.35% to £19.82 Friday, on what proved to be an all-around favorable ...
FDA approves first generic liraglutide once-daily injection
The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals) ...
조선일보6d
FDA approves generic Victoza, expects improved supply of obesity drug Saxenda
The generic of Victoza, developed by the U.K.'s Hikma Pharmaceuticals, is set to be launched across the United States by the ...